Natriuretic peptides were elevated in atrial fibrillation patients, with levels reflecting both atrial rhythm burden and underlying ventricular dysfunction — requiring AF-specific interpretation rather than standard HF cutoffs.
Key findingBNP and NT-proBNP were elevated in atrial fibrillation with levels influenced by rhythm burden AND underlying cardiac function, requiring AF-specific
What the researchers found
BNP and NT-proBNP were elevated in atrial fibrillation with levels influenced by rhythm burden AND underlying cardiac function, requiring AF-specific cutoff values for clinical interpretation rather than standard heart failure reference ranges.
Why it matters
Relevant for natriuretic-peptides, cardiovascular.
How the study worked
cross-sectional study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Natriuretic peptides in patients with atrial fibrillation.
Cardiology journal, 15(6), 525-9
Citation
Wozakowska-Kapłon, Beata; Opolski, Grzegorz; Herman, Zbigniew; Kosior, Dariusz. (2008). Natriuretic peptides in patients with atrial fibrillation.. Cardiology journal, 15(6), 525-9.